UCSF

Tagged: apoptosis

Research: Elusive drug targets; cell demolition enzymes; useful pharmacogenomics info

Predicting difficult-to-detect drug binding sites

Wells named a fellow of National Academy of Inventors

James Wells, PhD, whose pioneering innovations in protein engineering and technologies to identify small molecules to aid in drug discovery have yielded more than 60 patents, launched three companies, and created two UCSF technology centers, has been elected as a fellow to the National Academy of...

Wells elected member of American Academy of Arts and Sciences

James Wells, PhD, chair of the School’s Department of Pharmaceutical Chemistry, has been elected as a member of the 2015 class of the American Academy of Arts and Sciences.

New NIH funding awarded to the Department of Pharmaceutical Chemistry in 2011

New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included these on-going projects by faculty in the Department of Pharmaceutical Chemistry:

Wells uses small molecules to trigger cell death

Research directed by senior author James Wells, PhD, chair of the Department of Pharmaceutical Chemistry, UCSF School of Pharmacy, has opened the door to a new way of studying and better understanding the processes of cell death (apoptosis), blood clotting, and other biochemic